Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

doi:10.1002/cam4.3511

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	8923-8930
Number of pages	8
Journal	Cancer Medicine
Volume	9
Issue number	23
DOIs	https://doi.org/10.1002/cam4.3511
Publication status	Published - Dec 2020
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Keywords

Canada
United States
lenalidomide
newly diagnosed multiple myeloma
transplant-ineligible

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cam4.3511

Cite this

@article{d1bf5f713aa1412b873008c39e7b081e,

title = "Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients",

keywords = "Canada, United States, lenalidomide, newly diagnosed multiple myeloma, transplant-ineligible",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.",

year = "2020",

month = dec,

doi = "10.1002/cam4.3511",

language = "English",

volume = "9",

pages = "8923--8930",

journal = "Cancer Medicine",

issn = "2045-7634",

publisher = "John Wiley and Sons Ltd",

number = "23",

}

TY - JOUR

T1 - Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM

T2 - FIRST trial subanalysis of Canadian/US patients

PY - 2020/12

Y1 - 2020/12

KW - Canada

KW - United States

KW - lenalidomide

KW - newly diagnosed multiple myeloma

KW - transplant-ineligible

UR - http://www.scopus.com/inward/record.url?scp=85092348514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092348514&partnerID=8YFLogxK

U2 - 10.1002/cam4.3511

DO - 10.1002/cam4.3511

M3 - Article

C2 - 33049118

AN - SCOPUS:85092348514

SN - 2045-7634

VL - 9

SP - 8923

EP - 8930

JO - Cancer Medicine

JF - Cancer Medicine

IS - 23

ER -

Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this